annual CFF:
-$28.35M+$120.37M(+80.94%)Summary
- As of today (May 19, 2025), CORT annual cash flow from financing activities is -$28.35 million, with the most recent change of +$120.37 million (+80.94%) on December 31, 2024.
- During the last 3 years, CORT annual CFF has risen by +$274.24 million (+90.63%).
- CORT annual CFF is now -131.65% below its all-time high of $89.57 million, reached on December 31, 2012.
Performance
CORT Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$39.80M-$35.24M(-772.11%)Summary
- As of today (May 19, 2025), CORT quarterly cash flow from financing activities is -$39.80 million, with the most recent change of -$35.24 million (-772.11%) on March 31, 2025.
- Over the past year, CORT quarterly CFF has dropped by -$39.26 million (-7230.20%).
- CORT quarterly CFF is now -152.37% below its all-time high of $76.01 million, reached on September 30, 2012.
Performance
CORT quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$67.61M-$39.26M(-138.49%)Summary
- As of today (May 19, 2025), CORT TTM cash flow from financing activities is -$67.61 million, with the most recent change of -$39.26 million (-138.49%) on March 31, 2025.
- Over the past year, CORT TTM CFF has increased by +$81.84 million (+54.76%).
- CORT TTM CFF is now -175.48% below its all-time high of $89.57 million, reached on December 31, 2012.
Performance
CORT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CORT Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +80.9% | -7230.2% | +54.8% |
| 3 y3 years | +90.6% | -7766.2% | +73.7% |
| 5 y5 years | +1.0% | -10000.0% | -414.1% |
CORT Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -64.0% | +90.6% | -5296.2% | +72.7% | -1057.1% | +73.7% |
| 5 y | 5-year | -332.1% | +90.6% | -685.0% | +80.8% | -631.1% | +77.7% |
| alltime | all time | -131.7% | +90.6% | -152.4% | +80.8% | -175.5% | +77.7% |
CORT Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$39.80M(+772.1%) | -$67.61M(+138.5%) |
| Dec 2024 | -$28.35M(-80.9%) | -$4.56M(-78.4%) | -$28.35M(+23.2%) |
| Sep 2024 | - | -$21.09M(+881.0%) | -$23.02M(+294.0%) |
| Jun 2024 | - | -$2.15M(+295.9%) | -$5.84M(-96.1%) |
| Mar 2024 | - | -$543.00K(-170.9%) | -$149.45M(+0.5%) |
| Dec 2023 | -$148.72M(+760.5%) | $766.00K(-119.6%) | -$148.72M(-0.6%) |
| Sep 2023 | - | -$3.92M(-97.3%) | -$149.55M(-6.3%) |
| Jun 2023 | - | -$145.75M(<-9900.0%) | -$159.59M(+861.6%) |
| Mar 2023 | - | $181.00K(-396.7%) | -$16.60M(-4.0%) |
| Dec 2022 | -$17.28M(-94.3%) | -$61.00K(-99.6%) | -$17.28M(-92.3%) |
| Sep 2022 | - | -$13.96M(+406.6%) | -$224.19M(-4.1%) |
| Jun 2022 | - | -$2.76M(+444.7%) | -$233.87M(-9.1%) |
| Mar 2022 | - | -$506.00K(-99.8%) | -$257.15M(-15.0%) |
| Dec 2021 | -$302.59M(-2577.4%) | -$206.97M(+775.4%) | -$302.59M(+214.3%) |
| Sep 2021 | - | -$23.64M(-9.2%) | -$96.28M(+44.2%) |
| Jun 2021 | - | -$26.03M(-43.3%) | -$66.77M(+96.8%) |
| Mar 2021 | - | -$45.95M(+6851.1%) | -$33.94M(-377.9%) |
| Dec 2020 | $12.21M(-142.6%) | -$661.00K(-111.3%) | $12.21M(-4.1%) |
| Sep 2020 | - | $5.87M(-13.8%) | $12.73M(+33.2%) |
| Jun 2020 | - | $6.80M(+3219.0%) | $9.56M(-172.7%) |
| Mar 2020 | - | $205.00K(-242.4%) | -$13.15M(-54.1%) |
| Dec 2019 | -$28.64M(+99.8%) | -$144.00K(-105.3%) | -$28.64M(-29.3%) |
| Sep 2019 | - | $2.70M(-116.9%) | -$40.53M(-21.3%) |
| Jun 2019 | - | -$15.91M(+4.0%) | -$51.50M(+63.2%) |
| Mar 2019 | - | -$15.29M(+27.1%) | -$31.55M(+120.1%) |
| Dec 2018 | -$14.34M(+80.2%) | -$12.03M(+45.5%) | -$14.34M(-5550.6%) |
| Sep 2018 | - | -$8.27M(-304.5%) | $263.00K(-96.1%) |
| Jun 2018 | - | $4.04M(+110.4%) | $6.69M(-388.1%) |
| Mar 2018 | - | $1.92M(-25.1%) | -$2.32M(-70.8%) |
| Dec 2017 | -$7.95M(+12.1%) | $2.57M(-239.4%) | -$7.95M(-29.9%) |
| Sep 2017 | - | -$1.84M(-63.0%) | -$11.34M(-7.6%) |
| Jun 2017 | - | -$4.97M(+34.1%) | -$12.27M(+56.6%) |
| Mar 2017 | - | -$3.71M(+350.5%) | -$7.84M(+10.5%) |
| Dec 2016 | -$7.10M(-154.3%) | -$823.00K(-70.3%) | -$7.10M(+9.7%) |
| Sep 2016 | - | -$2.77M(+414.7%) | -$6.47M(+24.9%) |
| Jun 2016 | - | -$538.00K(-81.9%) | -$5.18M(-4.2%) |
| Mar 2016 | - | -$2.97M(+1421.0%) | -$5.41M(-141.4%) |
| Dec 2015 | $13.07M(-524.6%) | -$195.00K(-86.8%) | $13.07M(+7.7%) |
| Sep 2015 | - | -$1.48M(+93.3%) | $12.14M(-1.9%) |
| Jun 2015 | - | -$766.00K(-104.9%) | $12.37M(-1.2%) |
| Mar 2015 | - | $15.52M(-1474.3%) | $12.53M(-506.8%) |
| Dec 2014 | -$3.08M | -$1.13M(-9.6%) | -$3.08M(+21.1%) |
| Sep 2014 | - | -$1.25M(+104.1%) | -$2.54M(+52.1%) |
| Jun 2014 | - | -$612.00K(+587.6%) | -$1.67M(+57.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | -$89.00K(-85.0%) | -$1.06M(+9.2%) |
| Dec 2013 | -$970.00K(-101.1%) | -$592.00K(+56.6%) | -$970.00K(+457.5%) |
| Sep 2013 | - | -$378.00K(<-9900.0%) | -$174.00K(-100.2%) |
| Jun 2013 | - | $0.00(0.0%) | $76.21M(-0.3%) |
| Mar 2013 | - | $0.00(-100.0%) | $76.41M(-14.7%) |
| Dec 2012 | $89.57M(+110.8%) | $204.00K(-99.7%) | $89.57M(+0.2%) |
| Sep 2012 | - | $76.01M(>+9900.0%) | $89.41M(+553.5%) |
| Jun 2012 | - | $198.00K(-98.5%) | $13.68M(-0.3%) |
| Mar 2012 | - | $13.16M(>+9900.0%) | $13.72M(-67.7%) |
| Dec 2011 | $42.48M(+84.7%) | $45.00K(-84.1%) | $42.48M(-2.3%) |
| Sep 2011 | - | $283.00K(+19.9%) | $43.49M(+0.6%) |
| Jun 2011 | - | $236.00K(-99.4%) | $43.23M(-32.8%) |
| Mar 2011 | - | $41.92M(+3865.8%) | $64.35M(+179.8%) |
| Dec 2010 | $23.00M(-2.2%) | $1.06M(+6117.6%) | $23.00M(-41.7%) |
| Sep 2010 | - | $17.00K(-99.9%) | $39.47M(+0.1%) |
| Jun 2010 | - | $21.35M(+3659.5%) | $39.45M(+118.0%) |
| Mar 2010 | - | $568.00K(-96.8%) | $18.09M(-23.1%) |
| Dec 2009 | $23.52M(+21.8%) | $17.53M(<-9900.0%) | $23.52M(+295.2%) |
| Sep 2009 | - | -$3000.00(+50.0%) | $5.95M(-10.3%) |
| Jun 2009 | - | -$2000.00(-100.0%) | $6.64M(+3.4%) |
| Mar 2009 | - | $6.00M(<-9900.0%) | $6.42M(-66.8%) |
| Dec 2008 | $19.32M(+2.4%) | -$41.00K(-106.0%) | $19.32M(-0.2%) |
| Sep 2008 | - | $681.00K(-409.5%) | $19.36M(-32.5%) |
| Jun 2008 | - | -$220.00K(-101.2%) | $28.67M(-0.6%) |
| Mar 2008 | - | $18.90M(>+9900.0%) | $28.86M(+52.9%) |
| Dec 2007 | $18.87M(+536.0%) | $0.00(-100.0%) | $18.87M(-13.5%) |
| Sep 2007 | - | $10.00M(<-9900.0%) | $21.83M(+84.5%) |
| Jun 2007 | - | -$34.00K(-100.4%) | $11.83M(-0.4%) |
| Mar 2007 | - | $8.91M(+201.3%) | $11.88M(+300.2%) |
| Dec 2006 | $2.97M(>+9900.0%) | $2.96M(<-9900.0%) | $2.97M(>+9900.0%) |
| Sep 2006 | - | -$2000.00(-118.2%) | $23.00K(0.0%) |
| Jun 2006 | - | $11.00K(+1000.0%) | $23.00K(+76.9%) |
| Mar 2006 | - | $1000.00(-92.3%) | $13.00K(+8.3%) |
| Dec 2005 | $12.00K(-100.0%) | $13.00K(-750.0%) | $12.00K(-80.6%) |
| Sep 2005 | - | -$2000.00(-300.0%) | $62.00K(-2.7%) |
| Jun 2005 | - | $1000.00(>+9900.0%) | $63.70K(-99.9%) |
| Mar 2005 | - | $0.00(-100.0%) | $49.45M(+0.7%) |
| Dec 2004 | $49.09M(>+9900.0%) | $63.00K(<-9900.0%) | $49.09M(+0.1%) |
| Sep 2004 | - | -$300.00(-100.0%) | $49.03M(-0.0%) |
| Jun 2004 | - | $49.39M(<-9900.0%) | $49.03M(<-9900.0%) |
| Mar 2004 | - | -$360.00K(<-9900.0%) | -$322.40K(-957.4%) |
| Dec 2003 | $37.60K | $300.00(>+9900.0%) | $37.60K(+0.8%) |
| Sep 2003 | - | $0.00(-100.0%) | $37.30K(0.0%) |
| Jun 2003 | - | $37.30K(>+9900.0%) | $37.30K(>+9900.0%) |
| Mar 2003 | - | $0.00 | $0.00 |
FAQ
- What is Corcept Therapeutics Incorporated annual cash flow from financing activities?
- What is the all time high annual CFF for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual CFF year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly CFF year-on-year change?
- What is Corcept Therapeutics Incorporated TTM cash flow from financing activities?
- What is the all time high TTM CFF for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM CFF year-on-year change?
What is Corcept Therapeutics Incorporated annual cash flow from financing activities?
The current annual CFF of CORT is -$28.35M
What is the all time high annual CFF for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual cash flow from financing activities is $89.57M
What is Corcept Therapeutics Incorporated annual CFF year-on-year change?
Over the past year, CORT annual cash flow from financing activities has changed by +$120.37M (+80.94%)
What is Corcept Therapeutics Incorporated quarterly cash flow from financing activities?
The current quarterly CFF of CORT is -$39.80M
What is the all time high quarterly CFF for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly cash flow from financing activities is $76.01M
What is Corcept Therapeutics Incorporated quarterly CFF year-on-year change?
Over the past year, CORT quarterly cash flow from financing activities has changed by -$39.26M (-7230.20%)
What is Corcept Therapeutics Incorporated TTM cash flow from financing activities?
The current TTM CFF of CORT is -$67.61M
What is the all time high TTM CFF for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM cash flow from financing activities is $89.57M
What is Corcept Therapeutics Incorporated TTM CFF year-on-year change?
Over the past year, CORT TTM cash flow from financing activities has changed by +$81.84M (+54.76%)